RecruitingNCT06939738

Artificial Intelligence Scalable Solution for ST Myocardial Infarction

Artificial Intelligence Scalable Solution for ST Myocardial Infarction (ASSIST): Cross-sectional Study


Sponsor

Idoven 1903 S.L.

Enrollment

500 participants

Start Date

Apr 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The ASSIST clinical study is an observational, multicenter study to assess the performance of a cloud-based and AI-powered electrocardiogram (ECG) analysis platform, named Willem™, developed to detect Acute Myocardial Infarction (AMI). The main objectives are to compare Willem™ performance to detect and triage ECG patterns associated with AMI compared with human ECG interpretation, and to assess the time periods for both approaches.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age ≥ 18 years;
  • Available digitally stored 12-lead ECG traces prior to invasive coronary angiography;
  • Available angiographic and clinical data.

Exclusion Criteria4

  • ECGs with poor signal quality;
  • Lack of digitally stored 12-lead ECG traces prior to coronary angiography;
  • Previous coronary events (AMI, coronary revascularizations);
  • Non-available clinical or angiographic data.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(5)

Unidade Local de Saúde de São José

Lisbon, Portugal

Unidade Local de Saúde de Lisboa Ocidental

Lisbon, Portugal

Germans Trias i Pujol University Hospital

Barcelona, Spain

Hospital General Universitario Gregorio Marañón

Madrid, Spain

La Paz University Hospital

Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06939738


Related Trials